1994
DOI: 10.1021/bi00169a026
|View full text |Cite
|
Sign up to set email alerts
|

Apolipoprotein J Is Associated with Paraoxonase in Human Plasma

Abstract: Apolipoprotein J (apoJ)-containing high-density lipoproteins (HDL), isolated from human plasma by immunoaffinity chromatography, are associated with apoAI and a protein of approximately 44 kDa. In order to advance our understanding of apoJ's role in the vasculature, a comprehensive investigation was performed to identify and characterize this 44-kDa protein and to study its interaction with apoJ. The 44-kDa protein, a monomeric glycoyslated polypeptide, was identified by N-terminal sequencing as serum paraoxon… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

9
93
1
7

Year Published

1997
1997
2019
2019

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 166 publications
(113 citation statements)
references
References 44 publications
9
93
1
7
Order By: Relevance
“…3 and Table IV). Immunopurified PON1 is associated with two major proteins: apoA-I and apoJ (30,31), but PON3 seems to be more widely distributed than PON1 in the gel filtration HDL fractions (Fig. 3).…”
Section: Discussionmentioning
confidence: 99%
“…3 and Table IV). Immunopurified PON1 is associated with two major proteins: apoA-I and apoJ (30,31), but PON3 seems to be more widely distributed than PON1 in the gel filtration HDL fractions (Fig. 3).…”
Section: Discussionmentioning
confidence: 99%
“…In serum, paraoxonase appears to be restricted to and thus active within HDL particles. There is usually a defined stoichiometry concerning the apolipoproteins present in HDL complexes (30)(31)(32). If there is a defined number of paraoxonase molecules per HDL particle, activity of HDL containing B or L alleles will be less than that of HDL containing A or M alleles.…”
Section: Discussionmentioning
confidence: 99%
“…66 In that case, a potential application of these compounds as "soft drugs" for the treatment of asthma was postulated, 67 based on the nonubiquitous distribution of paraoxonase, and in particular on its absence from the lung tissue. 61 Soft drugs exert their therapeutic action in the target tissue and are then converted into inactive metabolites upon reaching the systemic circulation. In the literature, the soft drug strategy has been successfully exploited for topically applied drugs.…”
Section: Journal Of Medicinal Chemistrymentioning
confidence: 99%